BBC vs. DBE
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and DBE (Invesco DB Energy Fund) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while DBE is a Oil & Gas fund tracking the DBIQ Optimum Yield Energy Index. Both are passively managed. Over the past 10 years, BBC returned 10.71%/yr vs 11.45%/yr for DBE. At a 0.09 correlation, their price movements are largely independent. BBC charges 0.79%/yr vs 0.78%/yr for DBE.
Performance
BBC vs. DBE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 29.44% return, which is significantly lower than DBE's 68.39% return. Over the past 10 years, BBC has underperformed DBE with an annualized return of 10.71%, while DBE has yielded a comparatively higher 11.45% annualized return.
BBC
- 1D
- -3.75%
- 1M
- 16.02%
- 6M
- 23.66%
- YTD
- 29.44%
- 1Y
- 135.03%
- 3Y*
- 27.83%
- 5Y*
- 2.21%
- 10Y*
- 10.71%
DBE
- 1D
- -1.09%
- 1M
- 6.25%
- 6M
- 65.69%
- YTD
- 68.39%
- 1Y
- 57.64%
- 3Y*
- 17.96%
- 5Y*
- 17.10%
- 10Y*
- 11.45%
BBC vs. DBE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 29.44% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
DBE Invesco DB Energy Fund | 68.39% | -2.17% | 2.96% | -12.14% | 33.77% | 57.56% | -25.91% | 19.72% | -12.95% | 5.21% |
Correlation
The correlation between BBC and DBE is -0.23, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.02 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 2014 | 0.09 |
The correlation between BBC and DBE shifts across timeframes, from -0.23 (1 year) to 0.09 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. DBE — Risk / Return Rank
BBC
DBE
BBC vs. DBE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Invesco DB Energy Fund (DBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBC | DBE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.16 | ||
| Sortino ratioReturn per unit of downside risk | +1.96 | ||
| Omega ratioGain probability vs. loss probability | 1.50 | 1.28 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 9.00 | 2.34 | +6.65 |
| Martin ratioReturn relative to average drawdown | 26.02 | 7.00 | +19.03 |
Loading charts...
Drawdowns
BBC vs. DBE - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, smaller than the maximum DBE drawdown of -86.69%. Use the drawdown chart below to compare losses from any high point for BBC and DBE.
Loading charts...
Drawdown Indicators
| BBC | DBE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -86.69% | +9.84% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -24.72% | +9.62% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -24.72% | -29.73% |
Max Drawdown (5Y)Largest decline over 5 years | -70.92% | -38.74% | -32.18% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -60.84% | -16.01% |
Current DrawdownCurrent decline from peak | -16.91% | -36.07% | +19.16% |
Average DrawdownAverage peak-to-trough decline | -36.95% | -57.19% | +20.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.21% | 8.26% | -3.05% |
Volatility
BBC vs. DBE - Volatility Comparison
The current volatility for Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 11.01%, while Invesco DB Energy Fund (DBE) has a volatility of 11.68%. This indicates that BBC experiences smaller price fluctuations and is considered to be less risky than DBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | DBE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.01% | 11.68% | -0.67% |
Volatility (6M)Calculated over the trailing 6-month period | 26.56% | 32.70% | -6.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.14% | 35.99% | +0.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.59% | 29.88% | +9.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.71% | 28.39% | +9.32% |
BBC vs. DBE - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than DBE's 0.78% expense ratio.
Dividends
BBC vs. DBE - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.31%, less than DBE's 2.29% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.31% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
DBE Invesco DB Energy Fund | 2.29% | 3.86% | 6.32% | 3.87% | 0.75% | 0.00% | 0.00% | 1.79% | 1.67% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBC and DBE have a correlation of -0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DBE has higher volatility (11.68%) compared to BBC (11.01%). In terms of maximum drawdown, BBC dropped -76.85% vs DBE's -86.69%.
On 10-year performance, DBE leads with 11.45% vs 10.71% for BBC. On fees, DBE is cheaper at 0.78% per year. On volatility, BBC has been the lower-risk option at 11.01%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, DBE has performed better with a 11.45% return vs 10.71%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
DBE is cheaper with a 0.78% expense ratio, compared with 0.79% for BBC.
DBE has the higher dividend yield at 2.29%, compared with 1.31% for BBC.
BBC is categorized as Health & Biotech Equities, while DBE is Oil & Gas. BBC tracks LifeSci Biotechnology Clinical Trials Index, while DBE tracks DBIQ Optimum Yield Energy Index. They also come from different issuers: Virtus Investment Partners and Invesco. Their fees differ too: 0.79% for BBC and 0.78% for DBE.
BBC currently has the higher Sharpe Ratio (3.77 vs 1.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and DBE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer